Recent advances in NMR-based metabolomics

GA Nagana Gowda, D Raftery - Analytical Chemistry, 2017 - ACS Publications
NMR spectroscopy, one of the two major analytical platforms utilized in the metabolomics
field, has witnessed a large number of advances in fundamental studies, methods …

Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes

C Gar, M Rottenkolber, C Prehn, J Adamski… - Critical reviews in …, 2018 - Taylor & Francis
Presently, routine screening misses many cases of prediabetes and early type 2 diabetes
(T2D). Therefore, better biomarkers are needed for a simple and early detection of …

Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia

MM Banoei, HJ Vogel, AM Weljie, A Kumar, S Yende… - Critical Care, 2017 - Springer
Background Metabolomics is a tool that has been used for the diagnosis and prognosis of
specific diseases. The purpose of this study was to examine if metabolomics could be used …

Evolution of ARDS biomarkers: will metabolomics be the answer?

S Metwaly, A Cote, SJ Donnelly… - … of Physiology-Lung …, 2018 - journals.physiology.org
To date, there is no clinically agreed-upon diagnostic test for acute respiratory distress
syndrome (ARDS): the condition is still diagnosed on the basis of a constellation of clinical …

Development of metabolic and inflammatory mediator biomarker phenoty** for early diagnosis and triage of pediatric sepsis

B Mickiewicz, GC Thompson, J Blackwood, CN Jenne… - Critical care, 2015 - Springer
Introduction The first steps in goal-directed therapy for sepsis are early diagnosis followed
by appropriate triage. These steps are usually left to the physician's judgment, as there is no …

Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)

MM Banoei, HJ Vogel, AM Weljie, S Yende, DC Angus… - Critical Care, 2020 - Springer
Introduction Pneumonia is the most common cause of mortality from infectious diseases, the
second leading cause of nosocomial infection, and the leading cause of mortality among …

New strategies and challenges in lung proteomics and metabolomics. An official American Thoracic Society workshop report

RP Bowler, CH Wendt, MB Fessler… - Annals of the …, 2017 - atsjournals.org
This document presents the proceedings from the workshop entitled,“New Strategies and
Challenges in Lung Proteomics and Metabolomics” held February 4th–5th, 2016, in Denver …

Metabolomics: applications and promise in mycobacterial disease

M Mirsaeidi, MM Banoei, BW Winston… - Annals of the …, 2015 - atsjournals.org
Until recently, the study of mycobacterial diseases was trapped in culture-based technology
that is more than a century old. The use of nucleic acid amplification is changing this, and …

Pharmacometabolomics for the study of lipid-lowering therapies: opportunities and challenges

E Gianazza, M Brioschi, A Iezzi, G Paglia… - International Journal of …, 2023 - mdpi.com
Lipid-lowering therapies are widely used to prevent the development of atherosclerotic
cardiovascular disease (ASCVD) and related mortality worldwide.“Omics” technologies have …

Metabolomic and metallomic profile differences between veterans and civilians with pulmonary sarcoidosis

MM Banoei, I Iupe, RD Bazaz, M Campos, HJ Vogel… - Scientific reports, 2019 - nature.com
Sarcoidosis is a disorder characterized by granulomatous inflammation of unclear etiology.
In this study we evaluated whether veterans with sarcoidosis exhibited different plasma …